Jennifer Lavin1, Jin-Young Min1, Alcina K Lidder2, Julia He Huang1, Atsushi Kato3, Kent Lam4, Eric Meen5, Joan S Chmiel6, James Norton3, Lydia Suh3, Mahboobeh Mahdavinia7, Kathryn E Hulse3, David B Conley1, Rakesh K Chandra8, Stephanie Shintani-Smith1, Robert C Kern1, Robert P Schleimer1,2, Bruce K Tan1. 1. Department of Otolaryngology-Head and Neck SurgeryDivision of Pediatric Otolaryngology, Ann & Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago, Illinois, U.S.A. 2. University of Rochester School of Medicine and Dentistry, Rochester, New York, U.S.A. 3. Division of Allergy and Immunology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, U.S.A. 4. Department of Otolaryngology-Head and Neck Surgery, Eastern Virginia Medical School, Norfolk, Virginia, U.S.A. 5. Department of Otolaryngology-Head and Neck Surgery, University of Manitoba, Winnipeg, Canada. 6. Department of Preventive Medicine-Biostatistics, Northwestern University Feinberg School of Medicine, Chicago, Illinois, U.S.A. 7. Division of Allergy and Immunology, Rush Medical College, Chicago, Illinois, U.S.A. 8. Department of Otolaryngology, Head and Neck Surgery, Vanderbilt School of Medicine, Nashville, Tennessee, U.S.A.
Abstract
OBJECTIVE: To evaluate if molecular markers of eosinophilia in olfactory-enriched mucosa are associated with olfactory dysfunction. STUDY DESIGN: Cross-sectional study of tissue biopsies from 99 patients, and an additional 30 patients who underwent prospective olfactory testing prior to sinonasal procedures. METHODS: Tissue biopsies were processed for analysis of inflammatory markers using quantitative real time polymerase chain reaction (qRT-PCR). Ipsilateral olfactory performance was assessed using the Sniffin' Sticks (Burghart, Wedel, Germany) threshold component and the University of Pennsylvania Smell Identification Test (Sensonics, Haddon Heights, NJ). Age-adjusted data was correlated with inflammatory marker expression and clinical measures of obstruction from computed tomography and endoscopy. RESULTS: Gene expression of the eosinophil marker CLC (Charcot Leyden crystal protein) was elevated in superior turbinate (ST) tissue in chronic rhinosinusitis (CRS) with nasal polyps (CRSwNP) compared to ST and inferior turbinate tissue in CRS without nasal polyps (CRSsNP) and control patients (all P < 0.001, respectively). CLC in ST tissue was correlated with IL-5 and eotaxin-1 expression (all P < 0.001; P = 0.65, and 0.49, respectively). CLC expression was strongly correlated with eosinophilic cationic protein levels (P < 0.001; r = -0.76), and ST CLC expression was inversely related to olfactory threshold (P = 0.002, r = -0.57) and discrimination scores (P = 0.05, r = -0.42). In multiple linear regression of CLC gene expression, polyp status, and radiographic and endoscopic findings with olfactory threshold, CLC was the only significantly correlated variable (P < 0.05). CONCLUSION: Markers of eosinophils are elevated in the ST of patients with CRSwNP and correlate with olfactory loss. These findings support the hypothesis that olfactory dysfunction in CRS correlates local eosinophil influx into the olfactory cleft. LEVEL OF EVIDENCE: NA. Laryngoscope, 127:2210-2218, 2017.
OBJECTIVE: To evaluate if molecular markers of eosinophilia in olfactory-enriched mucosa are associated with olfactory dysfunction. STUDY DESIGN: Cross-sectional study of tissue biopsies from 99 patients, and an additional 30 patients who underwent prospective olfactory testing prior to sinonasal procedures. METHODS: Tissue biopsies were processed for analysis of inflammatory markers using quantitative real time polymerase chain reaction (qRT-PCR). Ipsilateral olfactory performance was assessed using the Sniffin' Sticks (Burghart, Wedel, Germany) threshold component and the University of Pennsylvania Smell Identification Test (Sensonics, Haddon Heights, NJ). Age-adjusted data was correlated with inflammatory marker expression and clinical measures of obstruction from computed tomography and endoscopy. RESULTS: Gene expression of the eosinophil marker CLC (Charcot Leyden crystal protein) was elevated in superior turbinate (ST) tissue in chronic rhinosinusitis (CRS) with nasal polyps (CRSwNP) compared to ST and inferior turbinate tissue in CRS without nasal polyps (CRSsNP) and control patients (all P < 0.001, respectively). CLC in ST tissue was correlated with IL-5 and eotaxin-1 expression (all P < 0.001; P = 0.65, and 0.49, respectively). CLC expression was strongly correlated with eosinophilic cationic protein levels (P < 0.001; r = -0.76), and ST CLC expression was inversely related to olfactory threshold (P = 0.002, r = -0.57) and discrimination scores (P = 0.05, r = -0.42). In multiple linear regression of CLC gene expression, polyp status, and radiographic and endoscopic findings with olfactory threshold, CLC was the only significantly correlated variable (P < 0.05). CONCLUSION: Markers of eosinophils are elevated in the ST of patients with CRSwNP and correlate with olfactory loss. These findings support the hypothesis that olfactory dysfunction in CRS correlates local eosinophil influx into the olfactory cleft. LEVEL OF EVIDENCE: NA. Laryngoscope, 127:2210-2218, 2017.
Authors: D C Lanza; D A Deems; R L Doty; D Moran; D Crawford; J C Rowley; A Sajjadian; D W Kennedy Journal: Laryngoscope Date: 1994-07 Impact factor: 3.325
Authors: Jin-Young Min; Christopher J Ocampo; Whitney W Stevens; Caroline P E Price; Christopher F Thompson; Tetsuya Homma; Julia H Huang; James E Norton; Lydia A Suh; Kathryn L Pothoven; David B Conley; Kevin C Welch; Stephanie Shintani-Smith; Anju T Peters; Leslie C Grammer; Kathleen E Harris; Kathryn E Hulse; Atsushi Kato; Nikolai N Modyanov; Robert C Kern; Robert P Schleimer; Bruce K Tan Journal: J Allergy Clin Immunol Date: 2016-10-04 Impact factor: 10.793
Authors: Eli P Darnell; Kristen E Wroblewski; Kristina L Pagel; David W Kern; Martha K McClintock; Jayant M Pinto Journal: Chem Senses Date: 2020-05-29 Impact factor: 3.160
Authors: Zachary M Soler; Frederick Yoo; Rodney J Schlosser; Jennifer Mulligan; Vijay R Ramakrishnan; Daniel M Beswick; Jeremiah A Alt; Jose L Mattos; Spencer C Payne; Kristina A Storck; Timothy L Smith Journal: Int Forum Allergy Rhinol Date: 2019-12-19 Impact factor: 3.858
Authors: Frederick Yoo; Zachary M Soler; Jennifer K Mulligan; Kristina A Storck; Jensine M Lamira; Whitney N Pasquini; Jonathan B Hill; Tegan E Noonan; Brandon J Washington; Rodney J Schlosser Journal: Int Forum Allergy Rhinol Date: 2019-08-23 Impact factor: 3.858
Authors: Whitney W Stevens; Anju T Peters; Bruce K Tan; Aiko I Klingler; Julie A Poposki; Kathryn E Hulse; Leslie C Grammer; Kevin C Welch; Stephanie S Smith; David B Conley; Robert C Kern; Robert P Schleimer; Atsushi Kato Journal: J Allergy Clin Immunol Pract Date: 2019-05-22
Authors: Ava R Weibman; Julia He Huang; Whitney W Stevens; Lydia A Suh; Caroline P E Price; Alcina K Lidder; David B Conley; Kevin C Welch; Stephanie Shintani-Smith; Anju T Peters; Leslie C Grammer; Atsushi Kato; Robert C Kern; Robert P Schleimer; Bruce K Tan Journal: Int Forum Allergy Rhinol Date: 2017-09-01 Impact factor: 3.858
Authors: Timothy L Smith; Rodney J Schlosser; Zachary M Soler; Jess C Mace; Jose L Mattos; Vijay R Ramakrishnan; Daniel M Beswick; Jeremiah A Alt; Jennifer K Mulligan Journal: Int Forum Allergy Rhinol Date: 2021-02-24 Impact factor: 5.426